Search Results for “Clinical Trial” – Page 113 – media

Biomarker for Noise Induced Hearing Loss

A new research collaborative study by Sensorion and UConn Health, presented at the 53rd American Neurotology Society Annual Spring Meeting, revealed the first potential biomarker for noise-induced hearing loss. The research team analyzed blood samples to check the level of serum prestin. The severity of hearing loss would be dependent upon the level of prestin circulated in the blood associated with the changes in an outer hair cell protein.
- Source: MedicalXpress
- 485
- June 28, 2018
biomarkers Hearing loss Researches
FDA Approval for Cannabis Based Epidiolex Medicine Against Seizures

Epidiolex, also known as purified cannabidiol was approved to treat Lennox-Gastaut syndrome and Dravet syndrome specifically in patients aged 2 and older. Both these conditions start during childhood. Recurrent seizures pose a huge risk of death.
- Source: FiercePharma
- 563
- June 27, 2018
FDA Medical marijuana New Approvals
Biotech Crinetics Therapeutics Raises $86 million in IPO

The San Diego-based biotech company Crinetics Therapeutics recently raised $86 million in an IPO. Prior to the new funding, the company received $63.5 million in series B funding and will see its lead asset through phase 2.
- Source: FierceBiotech
- 790
- June 26, 2018
biotech Clinical Trials endocrine disorders
Indian Healthcare Startup SigTuple Raised $19 Million AI Based Products Development

India, Bengaluru based SigTuple, a startup focusing on Artificial Intelligence for Healthcare has raised $19 million in their series B funding. The investment was led by IDG Ventures, pi Ventures Partners along with Accel, Axilor Ventures, VH Capital, Endiya Partners and Flipkart’s executive chairman Binny Bansal. The startup has also bagged venture debt from Trifecta Capital in this round. In an earlier investment round, the company raised $6.5 million from various investors.
- Source: Analytics India
- 704
- June 26, 2018
AI Company Insight digital health start ups
Re-Investigation on FDA Approved Anti-Gout Drug Uloric

When the FDA approved this drug, there was an additional demand from the FDA to conduct post-marketing studies and assess the drug’s safety. Recently, a non-profit consumer advocacy group sent a petition requesting that the FDA should eliminate the drug from the U.S. pharma market since the drug shows significant risk of cardiovascular diseases.
- Source: FiercePharma
- 673
- June 25, 2018
cardiovascular disease Clinical Trials gout Takeda
Smart Stent to Continuously Monitor Blood Flow

The smart stent looks similar to most commercial stents and uses medical-grade stainless steel. The researcher remarked that the devices as the first angioplasty smart stent, can be implanted in the patients without any modification in current medical procedures.
- Source: ScienceDaily
- 1,448
- June 22, 2018
Clinical Trials digital health medical device
Alta Partners Raise $130 Million Venture Capital for Biotech Development

San Francisco based Healthcare venture capital firm Alta Partners has launched funds titled as Alta Partner NextGen Fund I. The new fund will focus on the new development of therapeutics and health technology services. This will be the 9th fund in Alta Partners firms History.
- Source: FierceBiotech
- 614
- June 14, 2018
Company Insight healthcare technologies and innovations
Combination Drug Discovery Against Malaria

A team of scientists from Tubingen Institute of Tropical Medicine, and German company Deutschen Malaria GmbH, discovered a new combinational medicine which could effectively cure malarial without any side effects
- Source: drugdu
- 619
- June 4, 2018
Clinical Trials malaria
Crescendo and China’s Zai Labs Enters into Psoriasis Drug Deal

This is the second partnership of the firm, the first outside oncology. It has a USD 790 million collaboration signed in 2016 with drugmaker Takeda of Japan. The deal with Zai Lab is the first for Crescendo to involve a specific pipeline asset. The deal with Takeda was more of a platform agreement giving it the required confidence to collaborate with other programs in oncology.
- Source: Ddu
- 753
- June 1, 2018
Clinical Trials Company Insights psoriasis
Ava Raised $30 Million in Funding for Pregnancy Tracker Health Wearable

The company also announced that it service has recorded 10,000 pregnancies amongst its users. Ava launched its first wearable in 2016 and announced that the bracelet can detect a new pregnancy. Although it can be also be used to evade pregnancy.
- Source: drugdu
- 603
- May 31, 2018
Company Insight mHealth pregnancy wearables

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.